United States Oncology Diagnostics Market 2016-2017

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolidation, as participants [ ] The post United States Oncology Diagnostics Market 2016-2017 appeared first on STL News.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: